Device profile of the Proclaim XR neurostimulation system for the treatment of chronic pain: an overview of its safety and efficacy.

Jonathan M HagedornAlyson M EnglePriyanka GhoshTimothy R Deer

Published in: Expert review of medical devices (2020)

The Proclaim XR IPG is the newest and most advanced device in SCS technology. It is designed to meet the preferences of patients by providing burst low amplitude intermittent dosing in a recharge-free manner and a guaranteed 5-10 year battery life.

Keyphrases

chronic pain
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
high frequency
high intensity
combination therapy
resting state
replacement therapy